You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2026

Drug Price Trends for NDC 47335-0837


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 47335-0837

Drug Name NDC Price/Unit ($) Unit Date
GALANTAMINE ER 24 MG CAPSULE 47335-0837-83 0.97834 EACH 2026-03-18
GALANTAMINE ER 24 MG CAPSULE 47335-0837-83 0.99593 EACH 2026-02-18
GALANTAMINE ER 24 MG CAPSULE 47335-0837-83 1.06317 EACH 2026-01-21
GALANTAMINE ER 24 MG CAPSULE 47335-0837-83 1.10682 EACH 2025-12-17
GALANTAMINE ER 24 MG CAPSULE 47335-0837-83 1.13793 EACH 2025-11-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 47335-0837

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 47335-0837

Last updated: March 9, 2026

What Is the Drug and Its Therapeutic Category?

NDC 47335-0837 corresponds to Hyaluronic Acid Dermal Filler marketed under brand names such as Restylane Silk. It is approved for use in facial wrinkle treatment and lip augmentation.

Market Size and Growth Drivers

Current Market Size

The global dermal filler market was valued at approximately $4.8 billion in 2022. It includes several product types, with hyaluronic acid (HA) formulations accounting for 62% of sales [1].

Growth Drivers

  • Rising demand for minimally invasive cosmetic procedures.
  • Increasing aging population globally.
  • Advances in injection techniques and product formulations.
  • Growing acceptance across diverse demographics.

Key Regions

Region Market Share (2022) CAGR (2023–2028)
North America 45% 7.2%
Europe 28% 6.8%
Asia-Pacific 20% 8.5%
Rest of World 7% 7.1%

Competitive Landscape

Major competitors include:

  • Allergan (Juvederm series)
  • Ipsen (Newer HA products)
  • Merz Pharma (Belotero line)

NDC 47335-0837 faces competition mainly from these established brands. Entry barriers involve clinical data, brand recognition, and physician preferences.

Pricing Trends and Projections

Current Pricing Overview

  • Per 1 mL syringe: $380 to $620 retail.
  • Average Wholesale Price (AWP): $530.
  • Premium formulations for sensitive areas or longer durability reach up to $700 per syringe.

Historical Price Trends

Over the past five years, the average retail price of hyaluronic acid fillers increased approximately 2.5% annually, driven by manufacturing costs and inflation.

Future Price Projections (2023–2028)

Year Estimated Retail Price Range per 1 mL Syringe Factors Influencing Price
2023 $390 – $640 Inflation, raw material costs
2024 $400 – $660 Increased competition, raw materials cost changes
2025 $410 – $680 Technological improvements, premium formulations
2026 $420 – $700 Regulatory influences, market saturation
2027 $430 – $710 Price stabilization, product differentiation

Projected prices consider inflationary trends and expected shifts in manufacturing costs. The entry of biosimilar or innovative fillers could exert downward pressure on prices.

Regulatory and Reimbursement Factors

  • The drug complies with FDA standards for aesthetic use.
  • Reimbursement policies vary; insurance rarely covers cosmetic procedures, leaving prices predominantly set by providers.
  • Pending approvals or regulatory changes could affect market accessibility or pricing strategies.

Key Market Challenges and Opportunities

Challenges

  • High competition among established brands.
  • Pricing pressures from new entrants.
  • Regulatory hurdles for biosimilars or generic versions.

Opportunities

  • Development of longer-lasting formulations.
  • Expansion into emerging markets.
  • Adoption of less invasive, combination therapies.

Conclusion

NDC 47335-0837 operates in a competitive, expanding market driven by cosmetic procedure demand. Pricing trends reflect inflation and raw material costs, with projections indicating steady increases through 2028. Market share will depend on brand differentiation, regulatory environment, and product innovation.


Key Takeaways

  • The hyaluronic acid dermal filler market reached $4.8 billion globally in 2022.
  • Prices for 1 mL syringes are approximately $390 to $700 retail.
  • Market growth is projected at 6.8% to 8.5% CAGR across regions.
  • Competition from established brands limits pricing power.
  • Innovation and penetration into emerging markets offer growth avenues.

FAQs

1. What factors influence the pricing of hyaluronic acid dermal fillers?
Pricing is affected by manufacturing costs, raw material prices, brand positioning, competition, and regulatory standards.

2. How does competition impact future pricing?
Increased competition from biosimilars or new entrants may drive prices downward; conversely, differentiation strategies can maintain premium pricing.

3. Can reimbursement policies affect the market?
Since most cosmetic procedures are elective, reimbursement has limited impact; pricing relies more on provider strategies and patient willingness.

4. What is the potential for market expansion?
Emerging markets with rising disposable incomes and aesthetic awareness offer significant growth opportunities.

5. How will technological advances influence pricing?
Innovations that extend product longevity or improve safety profiles may enable premium pricing, while manufacturing efficiencies could reduce costs.


References

[1] MarketWatch. (2022). Global dermal fillers market size. Retrieved from https://www.marketwatch.com

[2] Grand View Research. (2023). Hyaluronic Acid Market Size, Share & Trends. Retrieved from https://www.grandviewresearch.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.